WallStreetZenWallStreetZen

NASDAQ: BHST
Bioharvest Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BHST

Based on 1 analyst offering 12 month price targets for Bioharvest Sciences Inc

Min Forecast
$14.00+96.08%
Avg Forecast
$14.00+96.08%
Max Forecast
$14.00+96.08%

Should I buy or sell BHST stock?

Based on 1 analyst offering ratings for Bioharvest Sciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BHST stock forecasts and price targets.

BHST stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-08

1 of 1

Forecast return on equity

Is BHST forecast to generate an efficient return?

Company
-262.6%
Industry
128.73%
Market
-49.34%
BHST's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BHST forecast to generate an efficient return on assets?

Company
39.89%
Industry
48.68%
BHST is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BHST earnings per share forecast

What is BHST's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.59
Avg 2 year Forecast
$0.06
Avg 3 year Forecast
$0.29

BHST revenue forecast

What is BHST's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$36.1M+19.52%
Avg 2 year Forecast
$59.4M+96.77%
Avg 3 year Forecast
$84.6M+180.29%
BHST's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BHST revenue growth forecast

How is BHST forecast to perform vs Biotechnology companies and vs the US market?

Company
40.82%
Industry
86.92%
Market
10.69%
BHST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BHST's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BHST vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BHST$7.14$14.00+96.08%Buy
IKT$1.66N/AN/A
PYXS$1.96$6.00+206.12%Strong Buy
PLX$1.58N/AN/A
HURA$2.52$12.00+376.19%Buy
View Top Biotech Stocks

Bioharvest Sciences Stock Forecast FAQ

Is Bioharvest Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BHST) stock is to Buy BHST stock.

Out of 1 analyst, 0 (0%) are recommending BHST as a Strong Buy, 1 (100%) are recommending BHST as a Buy, 0 (0%) are recommending BHST as a Hold, 0 (0%) are recommending BHST as a Sell, and 0 (0%) are recommending BHST as a Strong Sell.

If you're new to stock investing, here's how to buy Bioharvest Sciences stock.

What is BHST's earnings growth forecast for 2025-2027?

(NASDAQ: BHST) Bioharvest Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.08%.

Bioharvest Sciences's earnings in 2025 is -$12,063,000.On average, 2 Wall Street analysts forecast BHST's earnings for 2025 to be -$10,223,352, with the lowest BHST earnings forecast at -$11,263,015, and the highest BHST earnings forecast at -$9,183,689. On average, 2 Wall Street analysts forecast BHST's earnings for 2026 to be $1,039,663, with the lowest BHST earnings forecast at $693,109, and the highest BHST earnings forecast at $1,386,217.

In 2027, BHST is forecast to generate $5,025,038 in earnings, with the lowest earnings forecast at $5,025,038 and the highest earnings forecast at $5,025,038.

What is BHST's revenue growth forecast for 2025-2027?

(NASDAQ: BHST) Bioharvest Sciences's forecast annual revenue growth rate of 40.82% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.92%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.69%.

Bioharvest Sciences's revenue in 2025 is $30,192,000.On average, 2 Wall Street analysts forecast BHST's revenue for 2025 to be $625,270,632, with the lowest BHST revenue forecast at $618,599,461, and the highest BHST revenue forecast at $631,941,803. On average, 2 Wall Street analysts forecast BHST's revenue for 2026 to be $1,029,439,608, with the lowest BHST revenue forecast at $888,565,276, and the highest BHST revenue forecast at $1,170,313,939.

In 2027, BHST is forecast to generate $1,466,357,967 in revenue, with the lowest revenue forecast at $1,267,522,425 and the highest revenue forecast at $1,665,193,508.

What is BHST's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BHST) forecast ROA is 39.89%, which is lower than the forecast US Biotechnology industry average of 48.68%.

What is BHST's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BHST price target, the average BHST price target is $14.00, with the highest BHST stock price forecast at $14.00 and the lowest BHST stock price forecast at $14.00.

The Wall Street analyst predicted that Bioharvest Sciences's share price could reach $14.00 by Apr 8, 2026. The average Bioharvest Sciences stock price prediction forecasts a potential upside of 96.08% from the current BHST share price of $7.14.

What is BHST's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BHST) Bioharvest Sciences's current Earnings Per Share (EPS) is -$0.70. On average, analysts forecast that BHST's EPS will be -$0.59 for 2025, with the lowest EPS forecast at -$0.65, and the highest EPS forecast at -$0.53. On average, analysts forecast that BHST's EPS will be $0.06 for 2026, with the lowest EPS forecast at $0.04, and the highest EPS forecast at $0.08. In 2027, BHST's EPS is forecast to hit $0.29 (min: $0.29, max: $0.29).

What is BHST's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BHST) forecast ROE is -262.6%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.